With Tylenol Liver Damage Litigation Growing, Bernstein Liebhard LLP Notes New Report Highlighting Dangers of Acetaminophen

Share Article

The Firm is investigating Tylenol lawsuits on behalf of individuals who sustained serious liver injuries, allegedly due to the acetaminophen in over-the-counter brand Tylenol products.

Free Case Review
Our Firm has heard from numerous individuals who allegedly suffered serious liver problems due to the acetaminophen in Tylenol.

As Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes the publication of a new report that details the dangers potentially associated with acetaminophen, the active ingredient in dozens of over-the-counter medications, including those sold under the Tylenol brand name. The findings, which are based on an investigation conducted by Consumer Reports, revealed that acetaminophen overuse is now the leading cause of liver injuries in the U.S., and sends more than 80,000 people to the emergency room every year. Consumer Reports also detailed a Scottish study which found that exceeding just 4,000 milligrams of acetaminophen for just a few days can result in serious liver damage and other complications. Yet the daily limits recommended for many over-the-counter acetaminophen products come very close to this threshold.*

“Our Firm has heard from numerous individuals who allegedly suffered serious liver problems due to the acetaminophen in Tylenol. The revelations in this report serve to remind that products like Tylenol can be associated with some significant risks, despite their over-the-counter status,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Allegations
According to court documents, more than 160 Tylenol lawsuits are now pending in a federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. All of the complaints were filed on behalf of individuals who allegedly suffered acetaminophen-induced liver injuries resulting in hospitalization, liver transplantation or death, due to a Tylenol-brand product. The lawsuits further allege that severe liver injuries can occur with Tylenol use, even when the medications are used in accordance with package directions. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

In August 2013, Bloomberg.com reported that over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits of 325 mg per tablet mandated by the FDA for prescription medications.**

In January, the U.S. Food & Drug Administration (FDA) did finalize new guidance for the use of acetaminophen in prescription medications. However, these new guidelines do not apply to over-the-counter medications like Tylenol.***

Just last month, the FDA issued draft guidance regarding over-the-counter liquid pediatric medications that contain acetaminophen. According to the agency, the guidance is intended to address "ongoing concerns" about the potential for overdoses, which can result in serious adverse events including severe liver damage and death.****

Individuals who suffered liver damage allegedly related to the use of a Tylenol-brand over-the-counter medication may be entitled to compensation for their medical bills, lost wages, pain and suffering, and more. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*newsnet5.com/money/consumer/consumer-specialist/warning-about-acetaminophen-consumer-reports-investigates, Consumer Reports (via 5 ABC News) October 29, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
***federalregister.gov/articles/2011/01/14/2011-709/prescription-drug-products-containing-acetaminophen-actions-to-reduce-liver-injury-from, Federal Register, January 2014
****fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM417568.pdf, FDA, October 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website